The Jackson Laboratory is providing COVID-19 testing for hospitals and health care facilities in Connecticut and Maine

What are The Jackson Laboratory's qualifications for testing for COVID-19?

In order to conduct COVID-19 diagnostic testing, a laboratory must be CLIA (Clinical Laboratory Improvement Amendments) licensed for high complexity testing. The JAX-GM diagnostic laboratory is CLIA licensed for high complexity testing by the state of Connecticut and is also accredited by the College of American Pathologists (CAP), which ensures the laboratory is always up-to-date with the latest best practices in a variety of specialties, for example, molecular microbiology.

In 2013, JAX became a Connecticut-licensed and CLIA-registered clinical laboratory. CLIA regulates laboratory testing and requires clinical laboratories to be certified by the Center for Medicare and Medicaid Services (CMS) before they can accept human samples for diagnostic testing. CLIA registration means that the lab is qualified to accept and process clinical samples of human cells and tissues for DNA testing.

What are the COVID-19 tests used for?

JAX’s CLIA Laboratory’s testing will detect RNA sequences specific to the SARS-CoV-2 pathogen.

What technology will be utilized?

JAX’s CLIA Laboratory will be utilizing an FDA-approved, real-time, reverse transcription Polymerase Chain Reaction (PCR) detection technology for the COVID-19 diagnostic testing.